When the outliers were removed (Figure 9B, D), however, we found a significant increase in the RIOK2 mRNA level (P = .010) and a significant decrease in the miR‐4744 level (P = .025) in the pooled glioma group as compared to the nontumour group. This evidence concerns the gene RIOK2 and central nervous system cancer.